Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dahmen

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Der Anaesthesist|September 17, 2002
[Efficient OP management. Suggestions for optimisation of organisation and administration as a basis for establishing statutes for operating theatres]G Geldner, L H J Eberhart, S Trunk, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Der Anaesthesist|September 17, 2002
[Efficient OP management. Suggestions for optimisation of organisation and administration as a basis for establishing statutes for operating theatres]G Geldner, L H J Eberhart, S Trunk, et al.
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Pageof 9